SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2025-04-29
👔
ABBOTT LABORATORIES
@ABT_InsiderForm 4 Filing: Alpern Robert J Acquires (Grant) shares of $ABT
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
ABBOTT LABORATORIES
Ticker: $ABT
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2025-04-25
Shares: 1,635
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Alpern Robert J, holds the title of Director at ABBOTT LABORATORIES.
On 2025-04-25, the insider transacted 1,635 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Alpern Robert J (Director) was granted $0 of $ABT
Post-Transaction Position: 40,798 shares
SEC Accession No: 0001415889-25-011510 (CIK: 1448074)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.